Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

[The effect of a polarity intervention on the insomnia and anxiety in middle-aged Quebec women].

Lambert J, Ouellet N, Boucher D.

Rech Soins Infirm. 2019 Mar;(136):43-53. doi: 10.3917/rsi.136.0043. French.

PMID:
31210499
2.

Corrigendum to "Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadian" [Toxicol. Lett. 312 (2019) 148-156].

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Oct 1;313:207. doi: 10.1016/j.toxlet.2019.05.022. Epub 2019 Jun 8. No abstract available.

PMID:
31182248
3.

WITHDRAWN: Corrigendum to "Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadian" [Toxicol. Lett. 312 (2019) 148-156].

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Jun 1. pii: S0378-4274(19)30159-6. doi: 10.1016/j.toxlet.2019.05.020. [Epub ahead of print]

PMID:
31163208
4.

Selenoneine is a major selenium species in beluga skin and red blood cells of Inuit from Nunavik.

Achouba A, Dumas P, Ouellet N, Little M, Lemire M, Ayotte P.

Chemosphere. 2019 Aug;229:549-558. doi: 10.1016/j.chemosphere.2019.04.191. Epub 2019 Apr 30.

5.

Biomarkers of cadmium, lead and mercury exposure in relation with early biomarkers of renal dysfunction and diabetes: Results from a pilot study among aging Canadians.

Valcke M, Ouellet N, Dubé M, Laouan Sidi EA, LeBlanc A, Normandin L, Balion C, Ayotte P.

Toxicol Lett. 2019 Sep 15;312:148-156. doi: 10.1016/j.toxlet.2019.05.014. Epub 2019 May 14. Erratum in: Toxicol Lett. 2019 Jun 8;:.

PMID:
31100493
6.

Determinants of selenoneine concentration in red blood cells of Inuit from Nunavik (Northern Québec, Canada).

Little M, Achouba A, Dumas P, Ouellet N, Ayotte P, Lemire M.

Environ Int. 2019 Jun;127:243-252. doi: 10.1016/j.envint.2018.11.077. Epub 2019 Mar 28.

7.

Médicaments potentiellement inappropriés chez la personne âgée.

Ouellet N, Sirois C.

Perspect Infirm. 2018 Sep-Oct;15(4):52-60. French. No abstract available.

PMID:
30204356
8.

[An exploration of factors influencing nursing practice with families experiencing perinatal loss ].

Beaudoin MA, Ouellet N.

Rech Soins Infirm. 2018 Jun;(133):58-69. doi: 10.3917/rsi.133.0058. English, French.

PMID:
30066508
9.

Fin de vie. Des soins de confort chez soi.

Ouellet N, Sylvain H, Thériault H.

Perspect Infirm. 2017 Mar-Apr;14(2):48-51. French. No abstract available.

PMID:
29236370
10.

Eicosapentaenoic acid monoglyceride resolves inflammation in an ex vivo model of human peripheral blood mononuclear cell.

Morin C, Charbonneau L, Ouellet N, Ouellet H, Blier PU, Dufresne F, Fortin S.

Eur J Pharmacol. 2017 Jul 15;807:205-211. doi: 10.1016/j.ejphar.2017.05.018. Epub 2017 May 10.

PMID:
28501579
11.

Plasma levels of selenium-containing proteins in Inuit adults from Nunavik.

Achouba A, Dumas P, Ouellet N, Lemire M, Ayotte P.

Environ Int. 2016 Nov;96:8-15. doi: 10.1016/j.envint.2016.08.015. Epub 2016 Aug 30.

PMID:
27588697
12.

Unmet health care needs among sex workers in five census metropolitan areas of Canada.

Benoit C, Ouellet N, Jansson M.

Can J Public Health. 2016 Oct 20;107(3):e266-e271. doi: 10.17269/cjph.107.5178.

PMID:
27763841
13.

Community-dwelling older people's attitudes towards deprescribing in Canada.

Sirois C, Ouellet N, Reeve E.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):864-870. doi: 10.1016/j.sapharm.2016.08.006. Epub 2016 Aug 31.

PMID:
27663392
14.

Effects of intravenous benzo[a]pyrene dose administration on levels of exposure biomarkers, DNA adducts, and gene expression in rats.

Moreau M, Ouellet N, Ayotte P, Bouchard M.

J Toxicol Environ Health A. 2015;78(3):166-84. doi: 10.1080/15287394.2014.954072.

PMID:
25506633
15.

Repartnering After Widowhood.

Wu Z, Schimmele CM, Ouellet N.

J Gerontol B Psychol Sci Soc Sci. 2015 May;70(3):496-507. doi: 10.1093/geronb/gbu060. Epub 2014 Jun 12.

PMID:
24924159
16.

[Better knowledge about attracting and retaining geriatric nurses].

Sylvain H, Ouellet N, Guinchard B, Python NV.

Perspect Infirm. 2014 Mar-Apr;11(2):43-5. French. No abstract available.

PMID:
24672923
17.

Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.

Drescher O, Dewailly E, Diorio C, Ouellet N, Sidi EA, Abdous B, Valera B, Ayotte P.

J Expo Sci Environ Epidemiol. 2014 Nov;24(6):608-14. doi: 10.1038/jes.2013.96. Epub 2014 Jan 22.

PMID:
24448003
18.

[Careers of tomorrow].

Guinchard B, Python NV, Sylvain H, Ouellet N.

Krankenpfl Soins Infirm. 2013;106(12):61-3. French. No abstract available.

PMID:
24369553
19.

Persistent organic pollutants and transthyretin-bound thyroxin in plasma of Inuit women of childbearing age.

Audet-Delage Y, Ouellet N, Dallaire R, Dewailly E, Ayotte P.

Environ Sci Technol. 2013 Nov 19;47(22):13086-92. doi: 10.1021/es4027634. Epub 2013 Nov 11.

PMID:
24160776
20.

Relation between methylmercury exposure and plasma paraoxonase activity in inuit adults from Nunavik.

Ayotte P, Carrier A, Ouellet N, Boiteau V, Abdous B, Sidi EA, Château-Degat ML, Dewailly É.

Environ Health Perspect. 2011 Aug;119(8):1077-83. doi: 10.1289/ehp.1003296. Epub 2011 May 4.

21.

[State of research in various countries. Quebec, Canada].

Sylvain H, Ouellet N.

Rech Soins Infirm. 2010 Mar;(100):80-4. French. No abstract available.

PMID:
20419938
22.

[State of research in various countries. Canada].

Ouellet N, Sylvain H.

Rech Soins Infirm. 2010 Mar;(100):23-7. French. No abstract available.

PMID:
20419919
23.

Sleep satisfaction of older adults living in the community: identifying associated behavioral and health factors.

Ouellet N, Morris DL.

J Gerontol Nurs. 2006 Oct;32(10):5-11. doi: 10.3928/00989134-20061001-02.

PMID:
17048751
24.

[Screening for spousal abuse: the nurse's role].

Leblanc L, Ouellet N.

Perspect Infirm. 2004 May-Jun;1(5):39-43. Review. French. No abstract available.

PMID:
15171063
25.

Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection.

Jaramillo M, Plante I, Ouellet N, Vandal K, Tessier PA, Olivier M.

J Immunol. 2004 Mar 1;172(5):3101-10.

26.

[Psychosocial factors related to the use of psychotropic drugs in elderly persons].

Ouellet N, Beaulieu M.

Rech Soins Infirm. 2003 Sep;(74):38-46. French.

PMID:
14552208
27.

Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice.

Wang E, Simard M, Ouellet N, Bergeron Y, Beauchamp D, Bergeron MG.

Infect Immun. 2002 Aug;70(8):4226-38.

28.

Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia.

Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, Bergeron MG.

J Immunol. 2002 Feb 15;168(4):1813-22.

29.

Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice.

Wang E, Ouellet N, Simard M, Fillion I, Bergeron Y, Beauchamp D, Bergeron MG.

Infect Immun. 2001 Sep;69(9):5294-304.

30.

Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

Dallaire F, Ouellet N, Bergeron Y, Turmel V, Gauthier MC, Simard M, Bergeron MG.

J Infect Dis. 2001 Aug 1;184(3):292-300. Epub 2001 Jun 26. Erratum in: J Infect Dis 2001 Aug 1;184(3):392.

PMID:
11443554
31.

Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.

Fillion I, Ouellet N, Simard M, Bergeron Y, Sato S, Bergeron MG.

J Immunol. 2001 Jun 15;166(12):7353-61.

32.

Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment.

Dallaire F, Ouellet N, Simard M, Bergeron Y, Bergeron MG.

J Infect Dis. 2001 Jan 1;183(1):70-7. Epub 2000 Nov 15.

PMID:
11087202
33.

Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.

Wang E, Simard M, Ouellet N, Bergeron Y, Beauchamp D, Bergeron MG.

J Infect Dis. 2000 Oct;182(4):1255-9. Epub 2000 Sep 8.

PMID:
10979929
34.

Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.

Bergeron Y, Deslauriers AM, Ouellet N, Gauthier MC, Bergeron MG.

Antimicrob Agents Chemother. 1999 Sep;43(9):2291-4.

35.

Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.

Bergeron Y, Ouellet N, Simard M, Olivier M, Bergeron MG.

Antimicrob Agents Chemother. 1999 Sep;43(9):2283-90.

36.

Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice.

Duong M, Simard M, Bergeron Y, Ouellet N, Côté-Richer M, Bergeron MG.

Antimicrob Agents Chemother. 1998 Dec;42(12):3309-12.

37.

Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice.

Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG.

J Infect Dis. 1998 Nov;178(5):1472-82.

PMID:
9780270
38.

Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice.

Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG.

Antimicrob Agents Chemother. 1998 Oct;42(10):2527-33.

39.

Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.

Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG.

Infect Immun. 1998 Mar;66(3):912-22.

Supplemental Content

Loading ...
Support Center